Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Influenza

  Free Subscription


16.11.2026

1 Arch Virol
2 Drug Saf
3 J Gen Virol
1 N Engl J Med
1 Pediatrics
1 PLoS Comput Biol
1 PLoS Med
10 PLoS One
2 Proc Natl Acad Sci U S A
4 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arch Virol

  1. ASHRAF MA, Yue L, Raza MA, Shen B, et al
    Isolation, identification and whole genome sequence analysis of influenza B virus from Shanghai during 2023-2024.
    Arch Virol. 2026;171:317.
    PubMed         Abstract available


    Drug Saf

  2. ROMANSON B, Moro PL, Strid P, Hause A, et al
    Safety Monitoring of COVID-19 Vaccines in the Vaccine Adverse Event Reporting System (VAERS): United States, August 22, 2024-July 4, 2025.
    Drug Saf. 2026;49:1639-1648.
    PubMed         Abstract available

  3. TREGUNNO C, Deraedt Q, Cuadripani S, Verheust C, et al
    AS01(E)-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance.
    Drug Saf. 2026;49:1579-1594.
    PubMed         Abstract available


    J Gen Virol

  4. NAIR PM, Zhang Y, Starkey MR, Jhong HT, et al
    Mitogen-activated protein kinase p38-dependent phosphorylation of tristetraprolin enhances inflammatory and impairs antiviral responses to influenza virus.
    J Gen Virol. 2026;107.
    PubMed         Abstract available

  5. SOULTSIOTI M, Barcena M, Giera M, Snijder EJ, et al
    Pharmacological inhibition of coronavirus replication via modulation of host lipid metabolism.
    J Gen Virol. 2026;107:002362.
    PubMed         Abstract available

  6. BLOUQUIT-LAYE S, Cosentino G, Sitterlin D, Rameix-Welti MA, et al
    A ciliated epithelial cell line as a model for respiratory syncytial virus research.
    J Gen Virol. 2026;107.
    PubMed         Abstract available


    N Engl J Med

  7. ZHANG Q, Fouchier RAM, Moncada-Velez M, Meijer A, et al
    Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza.
    N Engl J Med. 2026;395:1963-1965.
    PubMed        


    Pediatrics

  8. JARAMILLO-CEREZO A, Parra-Buitrago A, Ulloa-Gutierrez R, Gutierrez-Tobar IF, et al
    Beyond Croup: A Phenotype-Based Perspective on Parainfluenza Virus Types in Children.
    Pediatrics. 2026 Nov 13:e2026078012. doi: 10.1542/peds.2026-078012.
    PubMed         Abstract available


    PLoS Comput Biol

  9. BECKER F, Sherratt K, Bosse NI, Funk S, et al
    The influence of ensemble size and composition on the performance of combined real-time COVID-19 forecasts.
    PLoS Comput Biol. 2026;22:e1014908.
    PubMed         Abstract available


    PLoS Med

  10. TALL S, Turtinen M, Parviainen A, Pettersson J, et al
    Trends in the incidence of childhood type 1 diabetes after the COVID-19 lockdown in Finland: An observational study.
    PLoS Med. 2026;23:e1005288.
    PubMed         Abstract available


    PLoS One

  11. CARMICHAEL HL, Groat D, Dinglas VD, Bose S, et al
    Association of unmet discharge needs on readmission or mortality among acute respiratory failure survivors during the COVID-19 pandemic: The Addressing Post-Intensive Care Syndrome (APICS-COVID) multicenter prospective cohort study.
    PLoS One. 2026;21:e0361770.
    PubMed         Abstract available

  12. LANG Y, Griffiths A
    Validation of chemical inactivation methods for Select Agent compliance using HPAIV and low-pathogenicity influenza A virus in tissues and cultured cells.
    PLoS One. 2026;21:e0362117.
    PubMed         Abstract available

  13. VERCHER G, Pleydell DRJ, Awada L, Tizzani P, et al
    Factors influencing the timeliness of reporting highly pathogenic avian influenza outbreaks in Europe.
    PLoS One. 2026;21:e0360917.
    PubMed         Abstract available

  14. PHILLIPS R, Wood F, Torrens-Burton A, Glennan C, et al
    Evolving concerns: A longitudinal content analysis of free-text reports from the UK COVID-19 Public Experiences (COPE) study cohort.
    PLoS One. 2026;21:e0348308.
    PubMed         Abstract available

  15. CHIBA A, Haganuma K, Nakata T, Nguyen TL, et al
    COVID-19 risk perceptions after the end of the public health emergency.
    PLoS One. 2026;21:e0348400.
    PubMed         Abstract available

  16. GOLD S, Bell F, Sheard E, Ashoori A, et al
    Characterising the longer-term impacts of highly pathogenic avian influenza outbreaks prior to 2020 on wild bird populations.
    PLoS One. 2026;21:e0360235.
    PubMed         Abstract available

  17. DAY SE, Sorresso G, Fitzpatrick M, Konty K, et al
    Estimating diabetes prevalence among NYC youth: Evidence from the Automated Student Health Record.
    PLoS One. 2026;21:e0344345.
    PubMed         Abstract available

  18. BATTAGLIA S, Attanasio M, Arnone S, Geraci A, et al
    Prolonged length of stay in the Italian emergency departments: A competing risks frailty model.
    PLoS One. 2026;21:e0361888.
    PubMed         Abstract available

  19. HAILE TG, Asres N, Gebregziabher D, Fissahaye B, et al
    Intimate partner violence against women in Ethiopia: An umbrella review of systematic reviews and meta-analyses.
    PLoS One. 2026;21:e0362748.
    PubMed         Abstract available

  20. HO TL, Pham TT, Ko EJ
    Combined monophosphoryl lipid A and alpha-Galactosyl ceramide adjuvants enhance the systemic immune response to intranasal inactivated influenza vaccination in a murine homologous challenge model.
    PLoS One. 2026;21:e0362356.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. ANKERHOLD J, Kessler S, Petric PP, Jakob C, et al
    Rare recovery of reassortants between contemporary clade 2.3.4.4b H5N1 viruses and human influenza A viruses in vitro.
    Proc Natl Acad Sci U S A. 2026;123:e2631654123.
    PubMed         Abstract available

  22. SU S, Tang YS, Li Q, Cao L, et al
    Predicting key viral mutations from within-host deep sequencing data.
    Proc Natl Acad Sci U S A. 2026;123:e2536820123.
    PubMed         Abstract available


    Vaccine

  23. SUN JW, Dodge LE, Cai S, Zhou L, et al
    Monitoring of adverse events following 2024-2025 BNT162b2 KP.2 COVID-19 vaccination in the United States.
    Vaccine. 2026;95:129296.
    PubMed         Abstract available

  24. KOCHMANN J, Halwe NJ, Barut GT, Ebert N, et al
    Boosting hybrid immunity with intranasal live-attenuated or intramuscular mRNA vaccination prevents SARS-CoV-2 XBB.1.5 transmission.
    Vaccine. 2026;95:129298.
    PubMed         Abstract available

  25. BROSZ A, Oberije J, Versage E, Elfassy A, et al
    Immunogenicity and safety of two priming doses of an MF59-adjuvanted cell-based H5N8 influenza vaccine in healthy persons aged >/=18?years.
    Vaccine. 2026;96:129279.
    PubMed         Abstract available

  26. NEMOTO M, Kawanishi N, Mita H, Kambayashi Y, et al
    Discrepancy between cross-neutralizing reactivity and protection in horses suggests inactivated vaccine antisera underestimate cross-protection against equine influenza.
    Vaccine. 2026;96:129339.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum